Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1647

1.

A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.

Fujisawa T, Joshi B, Nakajima A, Puri RK.

Cancer Res. 2009 Nov 15;69(22):8678-85. doi: 10.1158/0008-5472.CAN-09-2100. Epub 2009 Nov 3.

PMID:
19887609
[PubMed - indexed for MEDLINE]
Free Article
2.

Interleukin 13 mediates signal transduction through interleukin 13 receptor alpha2 in pancreatic ductal adenocarcinoma: role of IL-13 Pseudomonas exotoxin in pancreatic cancer therapy.

Shimamura T, Fujisawa T, Husain SR, Joshi B, Puri RK.

Clin Cancer Res. 2010 Jan 15;16(2):577-86. doi: 10.1158/1078-0432.CCR-09-2015. Epub 2010 Jan 12.

PMID:
20068108
[PubMed - indexed for MEDLINE]
Free Article
3.

IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer.

Fujisawa T, Joshi BH, Puri RK.

Int J Cancer. 2012 Jul 15;131(2):344-56. doi: 10.1002/ijc.26366. Epub 2011 Sep 16.

PMID:
21858811
[PubMed - indexed for MEDLINE]
4.

Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer.

Kawakami K, Kawakami M, Joshi BH, Puri RK.

Cancer Res. 2001 Aug 15;61(16):6194-200.

PMID:
11507072
[PubMed - indexed for MEDLINE]
Free Article
5.

Expression of IL-13Ralpha2 in liver cancer cells and its effect on targeted therapy of liver cancer.

Hou L, Du J, Wang J, Liu Y, Sun W, Zheng Y, Zhang L, Hu H, Dai X, Guan W, Ma Y, Hong T.

J Cancer Res Clin Oncol. 2010 Jun;136(6):839-46. doi: 10.1007/s00432-009-0724-z. Epub 2009 Nov 15.

PMID:
19916021
[PubMed - indexed for MEDLINE]
6.

Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.

Kioi M, Kawakami M, Shimamura T, Husain SR, Puri RK.

Cancer. 2006 Sep 15;107(6):1407-18.

PMID:
16902988
[PubMed - indexed for MEDLINE]
Free Article
7.

Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer.

Fujisawa T, Joshi BH, Puri RK.

J Transl Med. 2011 Apr 8;9:37. doi: 10.1186/1479-5876-9-37.

PMID:
21477288
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Autocrine motility factor signaling enhances pancreatic cancer metastasis.

Tsutsumi S, Yanagawa T, Shimura T, Kuwano H, Raz A.

Clin Cancer Res. 2004 Nov 15;10(22):7775-84.

PMID:
15570012
[PubMed - indexed for MEDLINE]
Free Article
9.

Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin.

Kioi M, Seetharam S, Puri RK.

Mol Cancer Ther. 2008 Jun;7(6):1579-87. doi: 10.1158/1535-7163.MCT-07-2131.

PMID:
18566228
[PubMed - indexed for MEDLINE]
Free Article
11.
12.

Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.

Zhu Z, Kleeff J, Kayed H, Wang L, Korc M, Büchler MW, Friess H.

Mol Carcinog. 2002 Nov;35(3):138-47.

PMID:
12410565
[PubMed - indexed for MEDLINE]
13.

Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo.

Kawakami K, Kawakami M, Husain SR, Puri RK.

Gene Ther. 2003 Jul;10(13):1116-28.

PMID:
12808442
[PubMed - indexed for MEDLINE]
14.
15.

PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.

Lee Y, Kim SJ, Park HD, Park EH, Huang SM, Jeon SB, Kim JM, Lim DS, Koh SS.

Oncogene. 2010 Jan 7;29(1):56-67. doi: 10.1038/onc.2009.298. Epub 2009 Sep 28.

PMID:
19784070
[PubMed - indexed for MEDLINE]
16.

KAI1 is a potential target for anti-metastasis in pancreatic cancer cells.

Xu JH, Guo XZ, Ren LN, Shao LC, Liu MP.

World J Gastroenterol. 2008 Feb 21;14(7):1126-32.

PMID:
18286698
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer.

Hibi T, Mori T, Fukuma M, Yamazaki K, Hashiguchi A, Yamada T, Tanabe M, Aiura K, Kawakami T, Ogiwara A, Kosuge T, Kitajima M, Kitagawa Y, Sakamoto M.

Clin Cancer Res. 2009 Apr 15;15(8):2864-71. doi: 10.1158/1078-0432.CCR-08-2946. Epub 2009 Apr 7.

PMID:
19351749
[PubMed - indexed for MEDLINE]
Free Article
18.

S100P promotes pancreatic cancer growth, survival, and invasion.

Arumugam T, Simeone DM, Van Golen K, Logsdon CD.

Clin Cancer Res. 2005 Aug 1;11(15):5356-64.

PMID:
16061848
[PubMed - indexed for MEDLINE]
Free Article
19.

Activation of two distinct MAPK pathways governs constitutive expression of matrix metalloproteinase-1 in human pancreatic cancer cell lines.

Endo H, Watanabe T, Sugioka Y, Niioka M, Inagaki Y, Okazaki I.

Int J Oncol. 2009 Dec;35(6):1237-45.

PMID:
19885545
[PubMed - indexed for MEDLINE]
20.

Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma.

Bister V, Skoog T, Virolainen S, Kiviluoto T, Puolakkainen P, Saarialho-Kere U.

Mod Pathol. 2007 Nov;20(11):1128-40. Epub 2007 Sep 14.

PMID:
17873896
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk